Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04770610 · ClinicalTrials.gov registry record · Phase 3
Study of OT-101 in Treating Myopia
A Phase 3 study of Myopia, Progressive, sponsored by Ocumension (Hong Kong) Limited.
- Active
- Registry status
- Phase 3
- Development phase
- 678
- Enrollment target
- 15
- Study locations
NCT04770610: Active Phase 3 study of Myopia, Progressive, sponsored by Ocumension (Hong Kong) Limited.
NCT04770610 is a Phase 3 study of Myopia, Progressive that is active but no longer recruiting, run by Ocumension (Hong Kong) Limited. The registered enrollment target is 678 participants. The trial reports 15 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04770610, a Phase 3 study of Myopia, Progressive, is active but no longer recruiting, sponsored by Ocumension (Hong Kong) Limited.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 678 participants
- Enrollment target
- 15
- Study locations
Study Summary
This is a phase III, randomized, double-masked, placebo-controlled, parallel-group, multicenter safety, tolerability, and efficacy study of atropine sulfate 0.01% (OT-101) as an investigational treatment for myopia in pediatric subjects
Conditions Studied
Interventions
- DRUG Vehicle
- DRUG OT-101 Ophthalmic Solution
Study Locations (15)
Pennsylvania
- Scott & Christie and Associates - Cranberry Township
- Pediatric Ophthalmology of Erie, Inc - Erie
- UPMC Children's Hospital - Pittsburgh
Colorado
- Colorado Vision Institute - Colorado Springs
- Eye Center of Northern Colorado, PC - Fort Collins
Florida
- Family Focus - Gainesville
- Pediatric Eye Consultants of North Florida - Jacksonville
North Carolina
- Pure Ophthalmic Research - Mint Hill
- CORE, Inc. - Shelby
Indiana
- Indiana University Health Physicians Pediatric Ophthalmology - Indianapolis
Maryland
- Kids Eye Care of Maryland - Rockville
Missouri
- Comprehensive Eye Care, Ltd. - Washington
Ohio
- University Hospitals Cleveland Medical Center - Cleveland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 678 participants |
| Start Date | 2021-04-01 |
| Est. Completion | 2027-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04770610
The ClinicalTrials.gov registry entry for NCT04770610 describes a study currently listed as active not recruiting, categorized as Phase 3. The registered enrollment target is 678 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ocumension (Hong Kong) Limited, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Myopia, Progressive appearing as the primary indexed condition, and to 2 interventions - of which Vehicle is the first listed.
NCT04770610 reports 15 study locations spanning 10 distinct geographic areas - top geographies include Pennsylvania, Colorado, Florida.
Frequently Asked Questions
What is clinical trial NCT04770610 about?
NCT04770610 is a clinical study titled "Study of OT-101 in Treating Myopia". This is a phase III, randomized, double-masked, placebo-controlled, parallel-group, multicenter safety, tolerability, and efficacy study of atropine sulfate 0.01% (OT-101) as an investigational treatment for myopia in pediatric subjects
What is the current status of trial NCT04770610?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 678 participants. The study started on 2021-04-01. Estimated completion is 2027-04.
What conditions does trial NCT04770610 study?
This clinical trial studies the following conditions: Myopia, Progressive.
What interventions are being tested in trial NCT04770610?
The interventions under investigation include: Vehicle (DRUG), OT-101 Ophthalmic Solution (DRUG).
Who is sponsoring clinical trial NCT04770610?
This trial is sponsored by Ocumension (Hong Kong) Limited, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04770610 being conducted?
This trial has 15 study locations across Colorado, Florida, Indiana, Maryland, Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia, Progressive
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.